NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Head-To-Head Review: Five Prime Therapeutics (NASDAQ:FPRX) vs. MOTIF BIO PLC/S (NASDAQ:MTFB)
06:16am, Tuesday, 04'th Feb 2020
Five Prime Therapeutics (NASDAQ:FPRX) and MOTIF BIO PLC/S (NASDAQ:MTFB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the stre
Brokerages Set Five Prime Therapeutics Inc (NASDAQ:FPRX) Price Target at $10.00
09:56am, Friday, 31'st Jan 2020
Five Prime Therapeutics Inc (NASDAQ:FPRX) has earned an average recommendation of “Hold” from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities
An Activist Fund Has Been Buying This Biotech
04:00pm, Friday, 17'th Jan 2020
When a fund files a 13D, it indicates that it intends to be an activist investor. Activist investors often facilitate new business paths, partnerships, and acquisitions.
An Activist Fund Owns 22% Of This Biotech
02:03pm, Thursday, 16'th Jan 2020
Identifying undervalued developmental Biotech companies that have the potential for a turn-around story, swing trade and/or investment can often times be reward
Progressive Care Surpasses $32M in 2019 Sales After Record-Breaking December, Provides Update on Uplisting Process
01:00pm, Thursday, 16'th Jan 2020
December performance brings 2019 sales to a close at $32.25 million (up 54% year-over-year) on more than 450,000 prescriptions filled (up 50% year-over-year), with Family Physicians Rx (FPRX) contribu
Prime Therapeutics hires new CFO, successor to Alec Mahmood
05:41pm, Friday, 10'th Jan 2020
Prime Therapeutics has hired David Schlett as its new chief financial officer. Schlett has executive experience at Express Scripts and Medco.
If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
02:28pm, Friday, 10'th Jan 2020
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) shareholders will doubtless be very grateful to see the share price up 33...
Five Prime Therapeutics (NASDAQ:FPRX) Will Have To Spend Its Cash Wisely
01:05pm, Friday, 10'th Jan 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Longtime biotech exec walks away from board to concentrate on startup
07:26pm, Friday, 27'th Dec 2019
Lewis "Rusty" Williams founded Five Prime Therapeutics nearly 20 years ago. Now he, the co-inventor of the cancer drug Opdivo and two other Five Prime executives are deep into a new startup.
Five Prime Therapeutics 13D From Biotech Value Fund Shows 21.4% Stake
12:00am, Friday, 27'th Dec 2019Five Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams From Board of Directors
09:05pm, Thursday, 26'th Dec 2019
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams from Board of Directors
